| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| Do | LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Mi | Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Co-Sponsoring International Scientific Conference on "Therapeutic Over-Activation in Cancer" | 1 | GlobeNewswire (USA) | ||
| 22.03. | LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 21.03. | Lixte Biotechnology Holdings, Inc.: LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments | 133 | GlobeNewswire (Europe) | -- Three Clinical Trials Currently Underway for Treating Ovarian, Lung and Sarcoma Cancers -- PASADENA, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the... ► Artikel lesen | |
| 19.03. | LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 26.02. | LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.02. | Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI | 364 | GlobeNewswire (Europe) | Agreement Focuses on Combining LIXTE's LB-100 with Various Innovative Cancer Immunotherapies PASADENA, CA, Feb. 26, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW)... ► Artikel lesen | |
| 29.01. | Lixte Biotechnology Holdings, Inc.: First Patient Dosed with LIXTE's LB-100 and GSK's Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial | 251 | GlobeNewswire (Europe) | PASADENA, CA, Jan. 29, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) ("LIXTE" or the "Company"), today announced the dosing of the first patient in a Phase 1b/2... ► Artikel lesen | |
| 28.11.23 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report | 2 | SEC Filings |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 895 |
| BAYER | 747 |
| TUI | 722 |
| NEL | 714 |
| SIEMENS ENERGY | 582 |
| RHEINMETALL | 465 |
| MERCEDES-BENZ | 455 |
| NVIDIA | 439 |
| DEUTSCHE BANK | 384 |
| BYD | 346 |
| NOVAVAX | 339 |
| RWE | 329 |
| ALLIANZ | 328 |
| PLUG POWER | 315 |
| K+S | 298 |
| VOLKSWAGEN | 296 |
| PALANTIR TECHNOLOGIES | 294 |
| COMMERZBANK | 269 |
| TESLA | 260 |
| AIXTRON SE | 255 |
| BASF | 253 |
| DEUTSCHE LUFTHANSA | 242 |
| THYSSENKRUPP | 231 |
| NORDEX | 229 |
| INFINEON | 228 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
